Timberlyne Therapeutics
San Diego
About Timberlyne Therapeutics
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $180.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: timberlyne-tx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/timberlyne-therapeutics-37128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.